123 related articles for article (PubMed ID: 7860211)
1. Serum immunosuppressive acidic protein in haemodialysis patients with and without acquired cystic disease of the kidney.
Sasagawa I; Nakada T; Kubota Y; Sawamura T
Int Urol Nephrol; 1994; 26(5):595-8. PubMed ID: 7860211
[TBL] [Abstract][Full Text] [Related]
2. Serum level of immunosuppressive acidic protein in haemodialysis patients with or without renal cell carcinoma.
Sasagawa I; Nakada T; Kubota Y; Suzuki H; Sawamura T
Br J Urol; 1994 Apr; 73(4):355-7. PubMed ID: 8199820
[TBL] [Abstract][Full Text] [Related]
3. Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment.
Edmunds ME; Devoy M; Tomson CR; Krishna U; Clayworth A; Durrant ST; Feehally J; Walls J
Br J Haematol; 1991 Jun; 78(2):275-7. PubMed ID: 2064967
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis.
Enoki Y; Katoh G; Okabe H; Yanagisawa A
Histopathology; 2010 Feb; 56(3):384-94. PubMed ID: 20459538
[TBL] [Abstract][Full Text] [Related]
5. [Acquired renal cystic disease].
Kawamura K; Ikeda R; Suzuki K
Hinyokika Kiyo; 2000 Sep; 46(9):651-6. PubMed ID: 11107538
[TBL] [Abstract][Full Text] [Related]
6. [Ultrasonographic study on kidneys in patients with chronic renal failure. Part II. Acquired cystic disease of the kidneys].
Yamaguchi S; Fujii H; Kaneko S; Yachiku S; Anzai T; Inada F; Kobayashi T; Furuta K; Ishida H
Nihon Hinyokika Gakkai Zasshi; 1990 Aug; 81(8):1183-9. PubMed ID: 2232409
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma in dialysis patients.
Sasagawa I; Nakada T; Kubota Y; Suzuki Y; Ishigooka M; Terasawa Y
Urol Int; 1994; 53(2):79-81. PubMed ID: 7801421
[TBL] [Abstract][Full Text] [Related]
8. Acquired cystic disease of the kidney and renal carcinoma in haemodialysis patients: ultrasonographic evaluation.
Sasagawa I; Terasawa Y; Imai K; Sekino H; Takahashi H
Br J Urol; 1992 Sep; 70(3):236-9. PubMed ID: 1422680
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of renal cell carcinoma and acquired cystic disease of the kidney in long-term dialysis patients].
Yokoyama O; Miyazaki K; Ishida T; Fujita Y; Miyazaki R; Muramoto H; Nakashima T; Watanabe K
Hinyokika Kiyo; 1991 Feb; 37(2):107-12. PubMed ID: 2048488
[TBL] [Abstract][Full Text] [Related]
10. [Renal cell carcinoma and acquired cystic disease of the kidneys in patients on long-term hemodialysis].
Ikeda R; Suzuki K; Tsugawa R
Hinyokika Kiyo; 1995 Sep; 41(9):709-17. PubMed ID: 7484538
[TBL] [Abstract][Full Text] [Related]
11. [Evidence for association between renal cell carcinomas and renal cystic diseases: nationwide survey in Japan].
Hatano T; Koyama Y; Hayakawa M; Ogawa Y; Osawa A
Nihon Hinyokika Gakkai Zasshi; 1996 Dec; 87(12):1297-304. PubMed ID: 8997077
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of renal cell carcinoma in dialysis patients: a single center experience].
Sakaguchi K; Ohmura M; Horiuchi S
Nihon Hinyokika Gakkai Zasshi; 2013 Jan; 104(1):6-11. PubMed ID: 23457927
[TBL] [Abstract][Full Text] [Related]
13. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O
Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
[TBL] [Abstract][Full Text] [Related]
14. Acquired cystic disease of the kidneys. Computed tomography and ultrasonography appraisal in patients on peritoneal and hemodialysis.
Jabour BA; Ralls PW; Tang WW; Boswell WD; Colletti PM; Feinstein EI; Massry SG
Invest Radiol; 1987 Sep; 22(9):728-32. PubMed ID: 3316110
[TBL] [Abstract][Full Text] [Related]
15. Acquired cystic disease of the kidney in patients with end-stage chronic renal failure: a study of prevalence and aetiology.
Thomson BJ; Jenkins DA; Allan PL; Elton RA; Winney RJ
Nephrol Dial Transplant; 1986; 1(1):38-43. PubMed ID: 3110661
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma].
Matsumoto K; Iwamura M; Muramoto M; Suyama K; Tabata K; Minei S; Hirai S; Baba S
Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):548-54. PubMed ID: 12056039
[TBL] [Abstract][Full Text] [Related]
17. Chloroform deposition in renal cyst fluid of hemodialysis patients with renal cystic disorders.
Ito F; Nakazawa H; Ohsaka Y; Yagisawa T; Kondo T; Hashimoto Y
Hum Exp Toxicol; 2008 Oct; 27(10):769-72. PubMed ID: 19042963
[TBL] [Abstract][Full Text] [Related]
18. Erythropoiesis in dialysis patients with acquired cystic kidney disease. Collaborative Group of Nephrologists of the East of France.
Schillinger F
Nephron; 1994; 66(1):119-20. PubMed ID: 8107946
[No Abstract] [Full Text] [Related]
19. Clinical importance of acquired cystic disease of the kidney in patients undergoing dialysis.
Ratcliffe PJ; Dunnill MS; Oliver DO
Br Med J (Clin Res Ed); 1983 Dec; 287(6408):1855-8. PubMed ID: 6423044
[TBL] [Abstract][Full Text] [Related]
20. [A study of the native kidneys in patients with chronic renal failure. Report 1: Morphological changes and occurrence of acquired cysts of the native kidneys in patients with chronic renal failure].
Fujita K
Nihon Hinyokika Gakkai Zasshi; 1990 Aug; 81(8):1140-7. PubMed ID: 2232404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
